Effect of acute and chronic administration of carbamazepine on cisplatin-induced hyperalgesia in rats

Jundishapur Journal of Natural Pharmaceutical Products

Volumn 7, Issue 1, 2012, Pages 25-28

  Nayebi, Alireza Mohajjel ^a,b   Sharifi, Hamdollah ^b   Ramadzani, Mohammad ^b   Rezazadeh, Hassan ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbamazepine; Cisplatin; Neuralgia

Indexed keywords

CARBAMAZEPINE; CISPLATIN; MORPHINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HYPERALGESIA; MALE; NEUROPATHIC PAIN; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; RAT; TAIL FLICK TEST;

EID: 84866750296     PISSN: 17357780     EISSN: 22287876     Source Type: Journal    
DOI: 10.5812/kowsar.17357780.3559     Document Type: Article

References (12)

1. James SE, Dunham M, Carrion-Jones M, Murashov A, Lu Q. Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin. Neurotoxicology. 2010;31 (2):l88-94.
2. Hori K, Ozaki N, Suzuki S, Sugiura Y. Upregulations of P2X(3) and ASIC3 involve in hyperalgesia induced by cisplatin administra tion in rats. Pain. 2010;149(2):393-405.
3. Authier N, Fialip J, Eschalier A, Coudore R Assessment of allo-dynia and hyperalgesia after cisplatin administration to rats. Neurosci Lett. 2000;291(2):73-6.
4. PacharinsakC, Beitz A. Animal models of cancer pain. Comp Med. 2008;58(3):220-33.
5. Iwamoto T, Takasugi Y, Higashino H, Ito H, Koga Y, Nakao S. Anti-nociceptive action of carbamazepine on thermal hypersensitive pain at spinal level in a rat model of adjuvant-induced chronic inflammation./Anesth. 2011;25(l):78-86.
6. Lemos L, Fontes R, Flores S, Oliveira P, Almeida A Effectiveness of the association between carbamazepine and peripheral an algesic block with ropivacaine for the treatment of trigeminal neuralgia./Pain Res. 2010;3:201-12.
7. Smith HS, Argoff CE. Pharmacological treatment of diabetic neu ropathic pain. Drugs. 2011;71(5):557-89.
8. Paice JA Mechanisms and management of neuropathic pain in cancer. Support Oncol 2003;1(2):107-20.
9. Joseph EK, Levine JD. Comparison of oxaliplatin- and cispla-tin-induced painful peripheral neuropathy in the rat. Pain. 2009;10(5):534-41.
10. Balayssac D, Cayre A, Ling B, Maublant J,Penault-Llorca F, Eschalier A, et al. Increase in morphine antinociceptive activity by a P-glycoprotein inhibitor in cisplatin-induced neuropathy. Neu-rosci Lett. 2009;465(l):108-12.
11. Shannon HE, Eberle EL, Peters SC. Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats. Neuropharmacology. 2005;48(7):1012-20.
12. Feng YH, Wang YW, Jim Yeung SC. Current concepts of pain man agement for cancer patients. Oncol Rev. 2008;2(3):154-63.